SecSonar.com

LeMaitre Vascular, Inc. (LMAT)

LeMaitre Vascular, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

LeMaitre Vascular, Inc. (LMAT) is a Medical - Instruments & Supplies company based in US with a market capitalization of $2.2B. Revenue grew 13.5% year-over-year and the company generated $74.5M in free cash flow. This page tracks LMAT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 651 employees · IPO Oct 19, 2006

Valuation

Valuation & price

$97.31 · as of May 17, 2026 · -17.1% vs 52w high

38.6

P/E ratio

Latest-FY diluted EPS

5.51

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$115$97.50$79.82Jul 25Dec 25Jul 26Jul 7, 25$82.98Jul 9, 25$84.55Jul 11, 25$83.69Jul 15, 25$82.23Jul 17, 25$82.10Jul 21, 25$79.82Jul 23, 25$82.16Jul 25, 25$82.43Jul 29, 25$82.44Jul 31, 25$81.24Aug 4, 25$84.36Aug 6, 25$93.23Aug 11, 25$92.62Aug 13, 25$95.15Aug 15, 25$95.91Aug 19, 25$95.33Aug 21, 25$96.45Aug 25, 25$97.60Aug 27, 25$95.68Aug 29, 25$95.37Sep 3, 25$94.56Sep 5, 25$97.49Sep 9, 25$95.62Sep 11, 25$94.23Sep 16, 25$92.45Sep 18, 25$93.42Sep 22, 25$92.29Sep 24, 25$87.80Sep 26, 25$84.19Sep 30, 25$87.51Oct 2, 25$86.87Oct 6, 25$87.49Oct 8, 25$88.04Oct 10, 25$86.05Oct 14, 25$87.38Oct 16, 25$86.84Oct 21, 25$89.75Oct 23, 25$89.01Oct 27, 25$90.12Oct 29, 25$88.87Oct 31, 25$86.61Nov 4, 25$87.26Nov 6, 25$85.60Nov 10, 25$87.79Nov 12, 25$89.97Nov 14, 25$88.44Nov 18, 25$86.48Nov 20, 25$84.44Nov 25, 25$83.49Nov 28, 25$82.95Dec 2, 25$83.68Dec 4, 25$85.70Dec 8, 25$82.93Dec 10, 25$83.66Dec 12, 25$84.00Dec 16, 25$83.41Dec 18, 25$85.27Dec 22, 25$84.51Dec 24, 25$84.34Dec 29, 25$82.96Jan 2, 26$80.17Jan 6, 26$83.51Jan 8, 26$85.04Jan 12, 26$83.83Jan 14, 26$85.46Jan 16, 26$88.27Jan 21, 26$86.99Jan 23, 26$84.22Jan 27, 26$85.33Jan 29, 26$83.86Feb 2, 26$86.39Feb 4, 26$86.79Feb 9, 26$86.54Feb 11, 26$87.78Feb 13, 26$87.66Feb 18, 26$90.61Feb 20, 26$92.94Feb 24, 26$90.75Feb 26, 26$113.69Mar 2, 26$107.40Mar 4, 26$106.41Mar 6, 26$107.39Mar 10, 26$109.20Mar 12, 26$106.54Mar 17, 26$112.23Mar 19, 26$109.00Mar 23, 26$107.86Mar 25, 26$111.08Mar 27, 26$106.62Mar 31, 26$109.17Apr 2, 26$108.49Apr 7, 26$110.33Apr 9, 26$112.71Apr 13, 26$115.17Apr 15, 26$114.81Apr 17, 26$114.36Apr 22, 26$112.80Apr 24, 26$113.45Apr 28, 26$112.40Apr 30, 26$109.75May 4, 26$111.53May 6, 26$110.22May 8, 26$107.94May 12, 26$97.22May 14, 26$99.50May 18, 26$100.83May 20, 26$101.43May 22, 26$97.75May 28, 26$94.54Jun 1, 26$91.42Jun 3, 26$91.64Jun 5, 26$94.48Jun 9, 26$96.59Jun 11, 26$92.34Jun 15, 26$91.92Jun 17, 26$92.21Jun 22, 26$88.61Jun 24, 26$92.25Jun 26, 26$95.66Jul 2, 26$101.03
$79.7752-week range$117.39
Loading valuation history…

Fundamentals

Key fundamentals

$2.2B

Market cap

13.5%

Revenue growth (YoY)

71.5%

Gross margin

$74.5M

Free cash flow (USD)

-$173.5M

Net debt

Net cash position

0.8%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$89.2MFY 2017$100.9MFY 2018$105.6MFY 2019$117.2MFY 2020$129.4MFY 2021$154.4MFY 2022$161.7MFY 2023$193.5MFY 2024$219.9MFY 2025$249.6M
$89.2M$249.6M

Free cash flow by year

2016 → 2025

FY 2016$14.1MFY 2017$16.5MFY 2018$16.5MFY 2019$10.4MFY 2020$31.8MFY 2021$30.2MFY 2022$22.1MFY 2023$29.5MFY 2024$37.2MFY 2025$74.5M
$14.1M$74.5M

Gross margin by year

2021 → 2025

FY 202165.7%FY 202264.9%FY 202365.7%FY 202468.6%FY 202571.5%
65.7%71.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

4

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 5, 2026Filing
  • Insider sellInsider Sell $434KJasinski Lawrence J · Director · $433.7KMay 11, 2026Filing
  • Insider sellInsider Sell $560KRoss Bridget A · Director · $560.4KMay 11, 2026Filing
  • Insider sellInsider Sell $313KKamke Trent G · Senior V. P., Operations · $313.3KMay 11, 2026Filing
  • Insider sellInsider Sell $5.0MLeMaitre George W · Director, Chairman and CEO · $5MMay 11, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • 8-K eventEarnings ReleaseMay 5, 2026Filing
  • 8-K eventDirector Departure and NominationApr 14, 2026Filing

Questions

Frequently asked questions

What is LeMaitre Vascular, Inc.'s market cap?

LeMaitre Vascular, Inc. (LMAT) has a market capitalization of $2.2B.

What is LMAT's P/E ratio?

LMAT trades at a price-to-earnings ratio of 38.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is LMAT's price-to-book (P/B) ratio?

LMAT trades at 5.51 times book value per share.

Are insiders buying LMAT stock?

SEC Form 4 filings show no open-market insider buys at LeMaitre Vascular, Inc. in the last 90 days (4 sells).

Same arena

Related companies in Medical - Instruments & Supplies

XRAY

DENTSPLY SIRONA Inc.

$2.1B

NVCR

NovoCure Limited

$2B

PLSE

Pulse Biosciences, Inc.

$1.8B

NNNN

Anbio Biotechnology Class A Ordinary Shares

$1.5B

STAA

STAAR Surgical Company

$1.5B

ATRC

AtriCure, Inc.

$1.4B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.